Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Warfarin for ischemic heart disease.

F W Verheugt1

  • 1Heartcenter, 540 Department of Cardiology, P.O. Box 9101, University Medical Center St Radboud, Nijmegen, The Netherlands.

Cardiology in Review
|November 7, 2001
PubMed
Summary

Oral anticoagulation effectively prevents recurrent ischemic events after myocardial infarction, outperforming placebo. However, aspirin is preferred due to similar efficacy and reduced bleeding risk compared to oral anticoagulants.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Passive smoking and the risk of coronary heart disease].

Nederlands tijdschrift voor geneeskunde·2004
Same author

[Reperfusion therapy for patients with an acute myocardial infarct with ST-segment elevation: fibrinolysis versus transport to a cardiac center for primary angioplasty].

Nederlands tijdschrift voor geneeskunde·2003
Same author

[Resuscitations in the hospital: reporting using the Utstein-style form and a study of 183 patients in the St. Radboud University Medical Center, Nijmegen, the Netherlands, between 1997-2000].

Nederlands tijdschrift voor geneeskunde·2003
Same author

Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA.

European heart journal·2001
Same author

The hotline sessions of the 23rd European congress of cardiology.

European heart journal·2001
Same author

Influence of planned six-month follow-up angiography on late outcome after percutaneous coronary intervention: a randomized study.

Journal of the American College of Cardiology·2001

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Oral anticoagulants were historically used for secondary ischemic heart disease prevention.
  • The advent of aspirin, particularly low-dose aspirin, reduced interest in oral anticoagulants due to bleeding risks.

Purpose of the Study:

  • To review the efficacy and safety of oral anticoagulation for ischemic heart disease.
  • To compare oral anticoagulation with placebo and low-dose aspirin.
  • To evaluate combination therapy of oral anticoagulants and aspirin versus aspirin alone.

Main Methods:

  • Review of existing literature on oral anticoagulation and aspirin in ischemic heart disease.
  • Comparison of outcomes including recurrent ischemic events and major bleeding.
  • Analysis of specific scenarios: post-myocardial infarction, coronary angioplasty, and post-coronary surgery.

Main Results:

  • Oral anticoagulation significantly reduces recurrent ischemic events post-myocardial infarction compared to placebo, with a major bleeding risk of 1 per 100 patient-years.
  • After myocardial infarction, oral anticoagulation shows similar efficacy to aspirin but with comparable excess bleeding, making aspirin preferable.
  • Combination therapy with oral anticoagulants and aspirin is superior to aspirin alone for preventing recurrent events if the international normalized ratio is maintained above 2.0, despite a similar bleeding risk.
  • Warfarin before coronary angioplasty shows promise, but not after intervention.
  • Long-term oral anticoagulation did not improve graft patency post-coronary surgery but improved survival in one trial.

Conclusions:

  • Aspirin is generally preferred over oral anticoagulation for secondary prevention post-myocardial infarction due to a better safety profile.
  • Combination therapy warrants consideration for specific high-risk patients undergoing interventions, balancing efficacy against bleeding risk.
  • The role of oral anticoagulation in specific cardiovascular interventions and surgeries requires further nuanced evaluation.

Related Experiment Videos